Viewing StudyNCT00796510



Ignite Creation Date: 2024-05-05 @ 9:02 PM
Last Modification Date: 2024-10-26 @ 9:58 AM
Study NCT ID: NCT00796510
Status: TERMINATED
Last Update Posted: 2018-10-25
First Post: 2008-11-20

Brief Title: Study Providing Monotherapy Sitaxsentan And Combination Therapy SitaxsentanSildenafil To Subjects With Pulmonary Arterial Hypertension PAH To Assess Long-Term Safety
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Pulmonary Hypertension
Pulmonary Arterial Hypertension
Keywords:
Name View
sitaxsentan View
endothelin receptor antagonist ETRA View